1 / 19

Multimechanistic Treatment for Coronary Artery Disease

Explore emerging strategies in managing coronary artery disease with a focus on blood glucose, lipids, and comprehensive treatment approaches. Learn about intensive statin therapy, fibrates, niacin, PPAR-γ effects, and clinical outcomes. Compare ACCORD and prior studies for insights.

iria
Download Presentation

Multimechanistic Treatment for Coronary Artery Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Blood Glucose, Lipids, and Coronary Artery Disease: Emerging Strategies for Multimechanistic Treatment

  2. Learning Objectives

  3. Patient Presentation

  4. Intensive Statin Therapy: Residual CV Risk

  5. Efficacy of Fibrates in Small Trials

  6. Comparison of ACCORD Subgroup Results With Those from Prior Fibrate Studies

  7. Comparison of ACCORD Subgroup Results With Those From Prior Fibrate Studies

  8. Efficacy of Niacin

  9. Coronary Drug Project: Clinical Outcomes

  10. AIM-HIGH: End Point at 36-month Follow-up

  11. Effect of Niacin on Major Vascular Events

  12. Patient Presentation

  13. PPAR- γ: Lipoprotein Effects of Pioglitazone in T2DM

  14. SYNCHRONY: Effect of Aleglitazar on Cardiometabolic Parameters in T2D

  15. ALECARDIO: Aleglitazar in Patients With T2D and ACS*

  16. Abbreviations (cont)

  17. Abbreviations

  18. References

  19. References (cont)

More Related